News & Analysis as of

State Attorneys General Federal Trade Commission (FTC) Cannabis Products

Troutman Pepper Locke

Congressional Briefing Highlights Growing Bipartisan Consensus on the Need for Federal Clarity in Hemp-Derived Cannabinoid...

Troutman Pepper Locke on

On July 17, the U.S. House Committee on Agriculture hosted a closed-door roundtable briefing focused on the regulatory gray areas surrounding hemp-derived cannabinoid products. The session, convened in response to ongoing...more

Cozen O'Connor

New Year, New FTC Chair & State AG Priorities

Cozen O'Connor on

Pennsylvania AG Dave Sunday was sworn in January 22, 2025. FTC Commissioner Andrew N. Ferguson was appointed Chairman on January 22, 2025....more

Cozen O'Connor

Nebraska AG Settles Delta-8 Lawsuits Against Four Retailers

Cozen O'Connor on

Nebraska AG Mike Hilgers has announced four additional settlements in a series of lawsuits filed against retailers for allegedly selling mislabeled and harmful products containing synthetic THC in violation of Nebraska’s...more

Cozen O'Connor

NRA Denied Bankruptcy | CBD False Advertising | Republican AGs Press for Energy Infrastructure

Cozen O'Connor on

FTC Continues Crackdown on Fake Claims About CBD - The Federal Trade Commission (“FTC”) reached a settlement with cannabidiol (“CBD”) products retailer Kushly Industries LLC and its sole officer (collectively, “Kushly”)...more

Cozen O'Connor

Anti-Discrimination Clarification From CFPB | $110 Million Charity Scam | Deceptive Claims re: CBD Cures

Cozen O'Connor on

2022 AG Elections- Kansas Attorney General Eyes Governor’s Mansion- •Kansas AG Derek Schmidt announced his candidacy for the Republican nomination for Governor in 2022. •Schmidt, who first assumed the AG’s office in...more

Cozen O'Connor

The State AG Report Weekly Update July 2019 # 3

Cozen O'Connor on

Cannabis/Marijuana- Bipartisan Coalition of 37 Attorneys General Submits Comment to FDA Regarding Cannabis Products- The National Association of Attorneys General (“NAAG”) submitted a comment to the U.S. Food and Drug...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide